Trump signs order formally cutting fentanyl tariffs against China to 10%

Former President Trump is in talks with Novo Nordisk, the maker of Ozempic, to negotiate a deal that could allow some weight-loss drugs to be sold for just $149. This move could also lead to Medicare and Medicaid coverage for these popular medications, benefiting many individuals seeking effective weight-loss solutions.

In a significant move, President Trump has re-nominated Jared Isaacman, a close ally of Elon Musk, for the position of NASA chief. This decision highlights the administration's commitment to advancing space exploration and innovation.

Matson has made a significant contribution by paying $6.4 million in port fees to China since the levies began in October. This investment highlights the company's commitment to maintaining strong trade relations.

Ebury, a UK-based cross-border payment firm, is set to increase its workforce in China. This decision comes as local companies are expanding their international trade and the yuan gains traction in global commerce.

Lawmakers are expressing optimism about reaching a bipartisan agreement to end the government shutdown. Meanwhile, President Trump has reiterated his call for Republicans to bypass Democrats and reopen the government by ending the Senate filibuster.

The Pentagon's new press policy has seen a shift as traditional journalists leave, making way for supporters of President Trump. Mike Lindell, owner of LindellTV, expressed enthusiasm about the changes, stating their commitment to making the administration proud.

In the latest episode of the Big Take Asia podcast, the discussion focuses on how major Asian economies are managing the increasing tensions between the US and China following the recent APEC summit.

Axon Enterprise, the maker of Tasers, has reported disappointing profits that fell short of expectations, leading to a significant drop in its shares. The company is facing challenges due to tariffs, which have impacted its financial performance.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.

Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.

Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.

Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.

Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.